Endothelin and scleroderma lung disease.

Rheumatology (Oxford, England)

Volumn 47 Suppl 5, Issue , 2008, Pages

  Silver, R M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; SULFONAMIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; DRUG ANTAGONISM; HUMAN; INTERSTITIAL LUNG DISEASE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMIC SCLEROSIS; TREATMENT FAILURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ENDOTHELIN-1; HUMANS; LUNG DISEASES, INTERSTITIAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ENDOTHELIN; SCLERODERMA, SYSTEMIC; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA; TREATMENT FAILURE;

EID: 65849500132     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: None     Document Type: Review

References (14)